Skip to main content
For Laboratory Research Use Only — Not for Human or Veterinary Use
KPV 10mg research peptide vial — Bulk Peptides Company

YOUR LOGO HERE

KPV

10mg

For Research Use Only

Lot: —

Bulk Peptides Co.

  • Third-party tested
  • ≥98% HPLC
  • COA per lot
Innate Immune Signaling Peptides

KPV

For Laboratory Research Use Only — Not for Human or Veterinary Use.

Standard (< 1,000 vials)$260/kit
Volume (1,000+ vials)$170/kit
= 10 vials

Minimum order: 100 vials total. Mix and match across all products.

Specifications
CAS Number67727-97-3
Molecular FormulaC16H30N4O4
Molecular Weight342.43 g/mol
Purity≥98% (HPLC)
FormLyophilized Powder
Storage-20°C, desiccated, protected from light
ReconstitutionBacteriostatic water
Certificate of Analysis

Lot documentation

Every production lot is independently third-party tested. A batch-specific Certificate of Analysis — documenting HPLC purity, mass spectrometry identity confirmation, and net peptide content — is issued with every shipment. View a sample COA to see the format.

Research context

The C-terminal tripeptide of alpha-melanocyte stimulating hormone, studied for activity that does not require melanocortin receptor engagement. Supplied lyophilised.

Structure and molecular target

KPV is the tripeptide lysine-proline-valine, corresponding to residues 11 to 13 of alpha-melanocyte stimulating hormone. At three residues it is among the smallest molecules in the catalogue, and that simplicity is central to what makes it interesting as a research article.

The parent hormone acts at melanocortin receptors, and the message sequence required for that binding is His-Phe-Arg-Trp at residues 6 to 9, which this fragment does not contain. The reported anti-inflammatory activity of the tripeptide therefore cannot be explained by melanocortin receptor agonism, and the published work associates it instead with intracellular interference in nuclear factor kappa B signalling.

Findings in the published research literature

In-vitro work centres on cultured epithelial and immune cell lines challenged with an inflammatory stimulus, with nuclear factor kappa B nuclear translocation and downstream cytokine expression as the standard readouts. Reported findings describe suppression of that signalling without engagement of a surface melanocortin receptor.

Because the tripeptide lacks the receptor-binding message sequence, a recurring question in the literature is how it enters cells at all, and peptide transporter-mediated uptake is the mechanism most often proposed. Rodent colitis models make up a substantial share of the in vivo work, chosen because the epithelium is accessible to a molecule of this size.

Analytical verification

A tripeptide is straightforward to verify and correspondingly easy to make well. Reversed-phase HPLC establishes purity and mass spectrometry confirms identity, reported per lot on the Certificate of Analysis. There is no cysteine, no terminal modification and no unnatural residue, so the impurity classes that complicate longer sequences do not arise.

The practical caution is the opposite of the usual one. A very short, very polar peptide is poorly retained on a standard reversed-phase column and can elute close to the void volume, where small-molecule impurities and residual counter-ion also appear. Confirming that the purity method actually resolves the peptide from the void is worth doing before relying on the reported figure.

Handling and storage

SolubilityFreely soluble in water; strongly polar and readily dissolved in aqueous buffer.
ReconstitutionDissolves immediately with gentle swirling.
StorageLyophilised powder at -20C, desiccated. Reconstituted solution at 2-8C.
StabilityChemically robust, with no oxidation- or disulfide-prone residues. The main practical risk with a peptide this small is loss through low-molecular-weight cutoff membranes during any filtration or dialysis step.

For Laboratory Research Use Only — Not for Human or Veterinary Use